Search the GHTC website
January 23, 2017

GHTC issues statement on R&D for epidemic diseases at WHO Executive Board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board, welcoming efforts by WHO to advance frameworks to catalyze development of new technologies to combat potentially epidemic diseases and support regulatory models and procurement systems to accelerate the pace at which these tools reach patients. The statement was issued in partnership with the Global Health Council and PATH.

November 15, 2016

GHTC sends letter urging WHO to establish an essential diagnostics list

GHTC sent a letter to the World Health Organization's (WHO) Assistant Director-General of Health Systems and Innovation urging WHO to support the establishment of an essential diagnostics list.

September 26, 2016

GHTC sends FY18 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the incoming president to prioritize global health R&D in his or her fiscal year 2018 (FY18) budget.

May 24, 2016

GHTC sends letter urging Senate to oppose provisions in Defense Authorization Act which could threaten medical research

GHTC sent a letter to members of the Senate Armed Services Committee and members of the Senate Appropriations Subcommittee on Defense urging them to oppose provisions in the fiscal year 2017 National Defense Authorization Act that would threaten medical research at the US Department of Defense.